About Avinger
Avinger is a company based in Redwood City (United States) founded in 2007. Avinger has raised $170.85 million across 10 funding rounds from investors including Zylox-Tonbridge, CRG and PDL BioPharma. Avinger offers products and services including Pantheris, Ocelot, TigerEye, and Lightbox. Avinger operates in a competitive market with competitors including Pathway Medical Technologies, Intact Vascular, LeMaitre Vascular, Cagent Vascular and Okami Medical, among others.
- Headquarter Redwood City, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$170.85 M (USD)
in 10 rounds
-
Latest Funding Round
$15 M (USD), Post-IPO
Mar 22, 2024
-
Investors
Zylox-Tonbridge
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Avinger
Avinger offers a comprehensive portfolio of products and services, including Pantheris, Ocelot, TigerEye, and Lightbox.
Image-guided tool for directional atherectomy in vascular disease.
Device for crossing chronic total occlusions with real-time imaging.
Provides onboard imaging for precise vascular interventions.
Console for operating image-guided vascular devices.
People of Avinger
Unlock access to complete
Unlock access to complete
Funding Insights of Avinger
Avinger has successfully raised a total of $170.85M across 10 strategic funding rounds. The most recent funding activity was a Post-IPO round of $15 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Avinger
Avinger has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Zylox-Tonbridge, CRG and PDL BioPharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CRG is recognized as a premier healthcare investment partner.
|
Locked | Locked | Locked | |
|
Biopharmaceutical company undergoing dissolution and asset distribution processes.
|
Locked | Locked | Locked | |
|
Medical equipment is manufactured by Zylox-Tonbridge in Hangzhou, China.
|
Locked | Locked | Locked |
Investor details for Avinger
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Avinger
Investment portfolio details for Avinger
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Avinger
Detailed financials for Avinger
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Avinger Comparisons
Peer comparison for Avinger
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Avinger
Avinger operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pathway Medical Technologies, Intact Vascular, LeMaitre Vascular, Cagent Vascular and Okami Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Smart devices are provided to clear peripheral arterial blockages.
|
|
| Locked | Locked | Locked |
Implants for repairing arteries after angioplasty are developed.
|
|
| Locked | Locked | Locked |
Devices for peripheral vascular disease treatment are developed and marketed.
|
|
| Locked | Locked | Locked |
Devices for removing vascular blockages are developed.
|
|
| Locked | Locked | Locked |
Innovative medical devices for peripheral vessel treatment are developed.
|
Detailed competitors of Avinger
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Avinger
Complete news archive for Avinger
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avinger
Avinger was founded in 2007 and raised its 1st funding round 3 years after it was founded.
Avinger is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Avinger is a funded company, having raised a total of $170.85M across 10 funding rounds to date.
Avinger was founded in 2007 as a commercial-stage medical device company based in Redwood City, United States. Catheter-based products guided by imaging technology are developed, manufactured, and sold for the treatment of peripheral artery disease. The product range includes the Lightbox imaging console and catheters such as Wildcat, Kittycat, and Ocelot, supporting interventions in the vascular sector.
Avinger's top competitors include Okami Medical, Cagent Vascular and LeMaitre Vascular.
Avinger offers Pantheris, Ocelot, TigerEye, and Lightbox.
Avinger has 3 investors. Key investors include Zylox-Tonbridge, CRG, and PDL BioPharma.